Introduction
Insulin detemir is a long-acting basal insulin analog used to manage blood glucose levels in individuals with diabetes mellitus. It provides a steady level of insulin over a 24-hour period and is designed to mimic the body's natural insulin release.
Uses
Insulin detemir is used for:
- Managing blood glucose levels in patients with type 1 diabetes mellitus (juvenile diabetes) and type 2 diabetes mellitus (adult-onset diabetes).
- It is used in combination with other insulin or oral antidiabetic agents to achieve better glycemic control.
| Brand Name | Insulin Detemir |
|---|---|
| Type | |
| Weight | |
| Generic | Insulin Detemir |
| Manufacturer | |
| Available in | English বাংলা |
Mechanism of Action
Insulin detemir works by promoting the uptake of glucose into cells, especially muscle and fat cells, and by inhibiting the production of glucose in the liver. It has a slower onset and prolonged duration of action compared to regular insulin, providing a steady level of insulin that helps maintain stable blood glucose levels throughout the day.
How Long Does It Take to Work?
Insulin detemir typically begins to work within 1-2 hours of injection, with its peak effect occurring between 6-8 hours. Its effects can last up to 24 hours, providing a steady and consistent insulin supply.
Absorption
Insulin detemir is absorbed slowly after subcutaneous injection, with peak plasma concentrations usually occurring around 6-8 hours post-injection. Its absorption rate is slower compared to other types of insulin, contributing to its extended duration of action.
Route of Elimination
Insulin detemir is metabolized primarily in the liver and kidney. It is degraded by insulin-degrading enzymes and excreted in the urine as inactive metabolites.
Dosage
Adult: In insulin-naive patients with type 2 DM who are not well controlled on oral antidiabetic drugs: Initial: 0.1 -0.2 unit/kg once daily in the evening or 10 unit 1-2 times/day, adjust subsequently based on glycaemic control.In patients on basal insulin only: May substitute with insulin detemir on a unit-for-unit basis based on the current basal insulin dosage, adjust subsequently to achieve glycaemic targets.
Dosage of insulin detemir is individualized based on the patient's needs and blood glucose levels:
- For type 1 diabetes: Typically started at 0.2 to 0.4 units/kg/day, administered once or twice daily.
- For type 2 diabetes: Typically started at 0.1 to 0.2 units/kg/day, administered once or twice daily.
Administration
Insulin detemir is administered via subcutaneous injection in the abdomen, thigh, or upper arm. It should be injected once or twice daily, as prescribed. Injection sites should be rotated to minimize the risk of lipodystrophy.
Side Effects
Common side effects include:
- Hypoglycemia (low blood sugar), which may cause symptoms like shaking, sweating, or dizziness.
- Injection site reactions such as redness or itching.
- Weight gain.
- Severe hypoglycemia or hyperglycemia.
- Allergic reactions, including anaphylaxis in rare cases.
Toxicity
Overdose of insulin detemir can lead to severe hypoglycemia, which may require prompt treatment with glucose or glucagon. Monitoring blood glucose levels closely is essential to avoid severe hypoglycemic episodes.
Precautions
Precautions include:
- Regular blood glucose monitoring to adjust insulin dosages as needed.
- Monitoring for signs of hypoglycemia or hyperglycemia.
- Educating patients on proper injection techniques and site rotation.
Interaction
Insulin detemir may interact with other medications, including:
- Oral hypoglycemic agents, which may require dose adjustments to avoid hypoglycemia.
- Certain medications (e.g., corticosteroids, diuretics) that may affect blood glucose levels.
Disease Interaction
Use with caution in patients with:
- Kidney or liver disease, as these conditions may affect insulin metabolism and clearance.
- Conditions that may affect glucose metabolism, such as adrenal or thyroid disorders.
Drug Interaction
Drug interactions can occur with:
- Beta-blockers, which may mask symptoms of hypoglycemia.
- Antidiabetic medications that may enhance or diminish insulin effects.
Food Interactions
Food intake can affect blood glucose levels and may necessitate adjustments in insulin dosage. Consistent carbohydrate intake helps maintain stable blood glucose levels.
Pregnancy Use
Insulin detemir is classified as Category B for pregnancy. It is generally considered safe during pregnancy, but blood glucose levels should be closely monitored and managed to avoid complications for both the mother and fetus.
Lactation Use
Insulin detemir is excreted in breast milk in small amounts. It is generally considered safe for use during lactation, but breastfeeding mothers should monitor their blood glucose levels and the infant’s health closely.
Acute Overdose
In cases of acute overdose, the primary concern is severe hypoglycemia. Treatment may involve glucose administration or glucagon injection, along with monitoring and supportive care.
Contraindication
Insulin detemir is contraindicated in patients with known hypersensitivity to insulin detemir or any of its components. Caution is advised in patients with conditions affecting glucose metabolism or those at risk of severe hypoglycemia.
Use Direction
Administer insulin detemir exactly as prescribed by your healthcare provider. Regular monitoring of blood glucose levels is essential. Do not alter dosage or administration frequency without medical advice.
Storage Conditions
Store insulin detemir in the refrigerator at 2-8°C (36-46°F) before opening. Once opened, it can be stored at room temperature (up to 30°C or 86°F) for up to 42 days. Keep out of direct sunlight and away from heat sources.
Volume of Distribution
The volume of distribution of insulin detemir is approximately 0.1 L/kg, reflecting its distribution primarily in the blood and tissues where insulin is active.
Half Life
The half-life of insulin detemir is approximately 5-7 hours, though its effects last up to 24 hours due to its slow absorption and extended duration of action.
Clearance
Insulin detemir is cleared from the bloodstream primarily through the liver and kidneys. Its clearance rate may be influenced by factors such as kidney or liver function.
See in details version Insulin Detemir also Insulin Detemir in bangla
